SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Imclone systems (IMCL)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
2515 89 0 IMCL
Emcee:  Deeber Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2465Courtesy of Yahoo Poster jbog2001, Goldman Sachs take on today's H&N restuck-11/16/2005
2464PIII H&N results for Erbitux: >>PHILADELPHIA--(BUSINESS WIRE)--Nov. 1tuck-11/16/2005
2463News flash re IMCL’s outgoing CEO, Dan Lynch… He’s working a book. The tentativDewDiligence_on_SI-11/10/2005
2462IMCL CEO "resigns" Message 21874349DewDiligence_on_SI-11/10/2005
2461OT <i>Moral - never trust a guy named Fuks </i> - or gal ;-( DocDoc Bones-11/10/2005
2460Great, that makes me feel even dumber for selling at 29.60tom pope-11/4/2005
2459Panitumumab’s success increases the chance of an IMCL buyout (IMHO): After PanDewDiligence_on_SI-11/4/2005
2458Well dummy that I am, after the opening gallop, I decided to sell if the gain drtom pope-11/4/2005
2457Nice strategy. I left a lot on the table by selling on a small dip after the optuck-11/4/2005
2456Two ImClone Holders To Pay $2.77 Million To Settle Charges <i>Reminder ofDoc Bones-11/4/2005
2455FWIW, this is from Yahoo IMCL board: finance.messages.yahoo.com "I've nRealMuLan-11/3/2005
2454<i>Thank you Dew. You often come across as a pain in the butt, but you alwDewDiligence_on_SI-11/3/2005
2453Thank you Dew. You often come across as a pain in the butt, but you always seem tom pope-11/3/2005
2452<i>It seemed to me - in retrospect - that IMCL's swoon deepened as theDewDiligence_on_SI-11/3/2005
2451I bought some of the stock this afternoon, a small position. I will hold over thtom pope-11/3/2005
2450Well, that abstract indicated to me that with marginal benefit for much greater tuck-11/3/2005
2449The fact that Pani succeeded in third-line CRC bolsters the notion that Pani andDewDiligence_on_SI-11/3/2005
2448My take, FWIW: finance.messages.yahoo.comDewDiligence_on_SI-11/3/2005
2447[Cetuximab With Paclitaxel and Carboplatin in Untreated Stage IV NSCLC] >>tuck-11/3/2005
2446Merrill's take from this a.m., before the ABGX news: Imclone Systems Inc. tom pope-11/3/2005
2445<u>Erbitux 3Q05 factoids</u> 17% of sales were in combination with DewDiligence_on_SI-10/27/2005
2444<b> Merck KGaA 3Q05 sales, profits up; Erbitux sales +15% quarter-over-quaDewDiligence_on_SI-10/25/2005
2443Merck KGaA to study Erbitux biomarkers: tinyurl.comDewDiligence_on_SI-10/24/2005
2442Notable re ADCC component of mAb’s for cancer: tinyurl.comDewDiligence_on_SI-10/24/2005
2441Briefing.com: Message 21810123DewDiligence_on_SI-10/20/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News